Literature DB >> 10395453

Structural investigations on human erythrocyte acylpeptide hydrolase by mass spectrometric procedures.

A Scaloni1, P Ingallinella, A Andolfo, W Jones, G Marino, J M Manning.   

Abstract

The complete primary structure of human erythrocyte acylpeptide hydrolase has been determined by using a combination of different mass spectrometric procedures and sequencing techniques. These data allowed us to correct the incomplete nucleotide sequence of the DNF15S2 locus on the short arm of human chromosome 3 at region 21, coding for the enzyme. The protein consists of 732 amino acid residues and is acetylated at the N-terminus. Alkylation experiments on the native enzyme demonstrated that all 17 cysteine residues present in the polypeptide chain are in reduced form. Multiple sequence alignment did not reveal striking similarity with proteases of known tertiary structure with the exception of members of the serine oligopeptidase family. Limited proteolysis experiments generated a C-terminal portion, containing all the catalytic triad elements responsible for proteolytic activity, and an N-terminal domain of unknown function, both still strongly associated in a completely active nicked form. The site of tryptic hydrolysis was identified as Arg193. The secondary structural organization of the protease domain of the enzyme is consistent with the alpha/beta hydrolase fold.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395453     DOI: 10.1023/a:1021047730831

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  2 in total

1.  Acylpeptide hydrolase (APEH) sequence variants with potential impact on the metabolism of the antiepileptic drug valproic acid.

Authors:  Despina Tsortouktzidis; Kathleen Grundke; Claudia Till; Anne Korwitz-Reichelt; Jörn Oliver Sass
Journal:  Metab Brain Dis       Date:  2019-07-30       Impact factor: 3.584

2.  Internalization of Erythrocyte Acylpeptide Hydrolase Is Required for Asexual Replication of Plasmodium falciparum.

Authors:  Rubayet Elahi; Christie Dapper; Michael Klemba
Journal:  mSphere       Date:  2019-05-08       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.